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We report a case of primary small cel carcinoma of the urinary bladder. A 74-year-old woman 
was referred to our hospital because of pollakiuria. Cystoscopy showed a papillary tumor. We 
operated transurethral resection of the bladder tumor (TUR-Bt). Histopathological finding was 
transitional cel carcinoma (TCC)， grade3， pTI containing pTis. About six months later， tumor 
recurred to the bladder. Pathologic diagnosis was TCC in part and most was small cel carcinoma. 
Pelvic magnetic resonance imaging revealed a huge mass lesion with extravesical extension in the 
urinary bladder， and computed tomography scan showed external iliac Iympho node metastasis. The 
rapid rise ofa tumor maker NSE and pro-GRP were remarkable. It was diagnosed as a rapid advance 
of small cel carcinoma. We performed pelvic radiotherapy ，and chemotherapy using carboplatin 
(CBDCA) and etoposide (VP-16). However 14months after it had left hospital， computed 
tomography showed paraaortic lympho node metastasis. The patient died due to rapidly progressive 
disease. 


















transitional cel carcinoma (TCC) ， G3， pTisを随伴
する pTlであった.術後 pirarubicinhydrochloride 
(THP-ADR) 20 mgの腸脱内注入を10団施行. 8月15
日のフォローアップの腸脱鏡にて前回とほぼ同部位に
(Hi町okikaKiyo 51 : 403-405， 2005) 
非乳頭状広基性腫蕩を認め， 9月10日，精査加療目的
にて当科入院した.
入院時現症:身長 149.3 cm体重 46目 7kg，血圧
108/60 mmHg脈拍 102/min整，体温 36.rc.胸腹部
に理学的異常所見を認めなかった.
入院時検査所見:一般血液にて RBC388X 10勺ul，
Hb 10. 1 g/dl， Ht 32. 4%と軽度の貧血を認め，生化学
検査にて CRP2.6 mg/dlと軽度の上昇を認めた.検
尿，尿沈j査にて潜血(+)， RBC 10-19/HPF， WBC 
5-9/HPFを認め，尿細胞診は陰性であった.腫蕩
マーカーの NSEは1.0 ng/ml (cut of 値 10ng/mO， 












404 泌尿紀要 51巻 6号 2005年
Fig. 1. Cystoscopy demonstrates a non papillary 
tumor on the posterior wall and dome of 
the urinary bladder. 
Fig. 2. Pelvic MRI (T2WI sagittal section) shows 
a rapid progression of the bladder tumor 







全身投与(合計 1，200mg)， VP-16 (合計 840mg)の
全身投与を 3コース施行.放射線療法は 60Gyの全
骨盤!照射を行った.腫場マーカーは治療開始後 lカ月
の時点で NSE2. 67 ng/ml， pro-GRP 26 pg/mlと陰性
化した. 2003年 l月の退院後も画像上 CR，腫蕩マー
カーも基準値内を推移と良好な経過を得ていたが，退
院後14カ月目の腹部CTにて傍大動脈リンパ節腫脹が









Fig. 3. A: Microscopic 白ndings (HE X 100) 
show a histological diagnosis of small cel 
carcinoma which is charcterized by cels 
with a high nuclear司to-cytoplasmatic
ratio. B: Immunohistochemical stain-
ing (X 400). The small cel carcinoma 
was stained positive for chrogranin A. 
Fig. 4. Pelvic CT scan shows the right external 

























































1) Cramer SF， Akikawa M and Cebelin M: 
N eurosecretory granules in smalJ celJ invasive 
carcinoma of the urinary bladder. Cancer 69目
527-536， 1992 
2) Blomjous CEM， Vos W， Voogt HJD， etal.: SmalJ 
celJ carcinoma of the urinary bladder. Cancer 64 : 
1347-1357. 1989 
3) Abbas F， Civation F， Soloway MS， etal. : SmalJ celJ 
carcinoma of the bladder and prostate. Urology 





小細胞癌の 2例.泌尿紀要 42: 595-599， 1996 
6)南 英利，金川賢司度遅美博，ほか:跨脱原発
小細胞癌の l例.泌尿器外科 14:247-251， 
2001 
7) Mackey JR， Au HJ， Venner P， etal.: Genitourinary 
smalJ celJ carcinoma : determination of clinical and 
therapeutic factors associated with survival. J 
Urol159・1624-1629，1998 
8) Bastus R， CabalJero JM， Gonzalez G， etal. : SmalJ 
celJ carcinoma of the urinary bladder treated with 
chemotherapy and radiotherapy results in five 
cases. Eur U rol 35: 323-326， 1999 
9)山口史朗，石津和彦，藤川公樹，ほか :CDDP
併用放射線療法が奏効した跨脱原発神経内分泌癌
のl例.泌尿紀要 45: 489-492， 1999 
10) Noda K， Nishiwaki Y， Kawahara M， et al. 
Randomized phase I study of irinotecan (CPT-
11) and cisplatin versus etoposide and cisplatin in 
extensive-disease smalJ-celJ lung cancer: J apan 
Clinical Oncology Group study OCOG9511) 
Proc Am Soc Clin Oncol 19: 483， 2000 
(RECE山 nAugu山川
Accepted on恥1arch 6， 20051 
